Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Stiefel Jennifer D HDirector, President & Secretary | Option exercise | M | — 208 sh | Nov 4, 2026 |
| 13 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Flavin LisaSenior VP & CCO | Grant or award | A | — 14.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Lin AlfredDirector | Other acquisition or disposition | J | — 254.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Hooks Michael K.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Kasbar Michael JDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $72K 1,938 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chandra SunilDirector | Grant or award | A | $32K 550 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Piazza Nicholas J.Senior VP & CPO | Grant or award | A | — 12.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Utterback Cynthia ADirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chemodurow TanyaDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Cape ShavonDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Linnane Robert13D Group Member | Tax withholding | F | $17K 608 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Baughman Michael JExec VP, CFO & CAO | Grant or award | A | — 13.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rubin ElaineDirector | Grant or award | A | $18K 40.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $240K 1,759 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Spaulding MirandaEVP - CFO | Grant or award | A | — 2,429 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ludwig Jeffrey G.Director, President & CEO | Tax withholding | F | $93K 2,814 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Gemayel GeorgesDirector | Other acquisition or disposition | J | — 8,613 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | Other acquisition or disposition | J | — 8,613 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Runnette Deirdre L.Chief Legal Officer | Tax withholding | F | $238K 39.9K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | Other acquisition or disposition | J | — 6,847 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | Other acquisition or disposition | J | — 70.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $1.70M 4,846 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | Other acquisition or disposition | J | — 6,847 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Fenimore Christopher R.EVP Finance CFO | Gift | G | — 15 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | Other acquisition or disposition | J | — 40.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | Other acquisition or disposition | J | — 50.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mitra SabyaschiGroup President | Tax withholding | F | $79K 477 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector | Open-market sale · 10b5-1 plan | SELL | $83K 1,841 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Burchianti RalphDirector | Option exercise | M | $74K 2,810 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |